PhD candidate at Zhejiang University, focusing on liver tissue engineering, biliary reconstruction, and bioengineered liver development.

Meina Cai is a research fellow at Mayo Clinic, where she studies liver injury, fibrosis, and regeneration. Her research focuses on understanding how chronic liver disease affects the regenerative response. Her work aims to identify underlying mechanisms and potential therapeutic strategies to reduce liver injury and enhance regeneration.

From the University of Zurich

Takeshi Saito, M.D., Ph.D., is a physician scientist and currently Associate Professor of Medicine at Keck School of Medicine, University of Southern California. His research interest has been centered on the innate immunity and inflammation of the liver in the context of viral hepatitis (HCV, HBV, and HDV), and metabolic liver diseases (alcoholic liver disease and NAFLD).

Dr. Tomoya Hamabe is a researcher/physician in the Department of Gastroenterology and Hepatology,
The University of Osaka Graduate School of Medicine, Japan. His research focuses on understanding the mechanisms of hepatocyte cell death in liver diseases.

Kenta Makino, MD, PhD, is a surgeon–scientist in the Division of Hepato-Biliary-Pancreatic Surgery and
Transplantation, Department of Surgery, Kyoto University (Japan), and a Research Fellow in the Ting Lab
at the Massachusetts General Hospital Krantz Family Center for Cancer Research. His work focuses on
spatial transcriptomics of intrahepatic cholangiocarcinoma.

I am a Computational Biologist in the Bruce Wang Lab at the University of California, San Francisco. My expertise spans bulk, single-cell, single-nuclei, and spatial transcriptomics. I focus on building scalable, reproducible pipelines for multi-omics data integration using Python, R, and Bash in high-performance computing and cloud-based environments. At UCSF, I apply next-generation sequencing analysis, statistical modeling, and machine learning to investigate liver disease and injury, including hepatoblastoma, biliary atresia, autoimmune hepatitis, and acute hepatic porphyria.

I am currently a Postdoctoral Research Fellow in the Division of Gastroenterology and Hepatology at the Mayo Clinic, where my research centers on investigating how BAP1 loss-induced metabolic alterations drive immune escape and how these mechanisms can be leveraged to enhance the efficacy of cancer immunotherapy, with a particular emphasis on cholangiocarcinoma (CCA).